Evidence supports the use of long-acting injectable (LAI) antipsychotics in the treatment and prevention psychosis, but these formulations remain under-used in the UK. Overall, LAIs offer many advantages and the advent of second-generation LAIs increased interest in injectables as these newer drugs offer similar benefits to their oral equivalents. LAIs should be one of the options discussed with patients requiring long-term treatment
Background Long-acting injectable (LAI) antipsychotics have been shown to reduce risk of relapse in ...
INTRODUCTION: Long-acting injectable (LAI) antipsychotics are a useful but underutilized op...
Despite mixed results found in literature, long-acting injectable antipsychotics (LAIs) should offe...
Schizophrenia is a severe mental illness causing a high degree of disability. First-and second-gener...
AbstractObjectiveAs psychopathology and social functioning can worsen with repeated psychotic episod...
Background: Long acting injectable antipsychotics (LAI-APs) are considered a major advance in psychi...
International audienceBACKGROUND: Long-acting injectable (LAI) formulations are not widely used in r...
Purpose/Background Psychosis is a psychiatric disorder characterized by hallucinations and delusions...
Until relatively recently, long-acting injectable (LAI) formulations were only available for first-g...
Background: Long acting injectable (LAI) antipsychotics have been claimed to ensure treatment adhere...
Until relatively recently, long-acting injectable (LAI) formulations were only available for first-g...
Long-acting injectable (LAI) antipsychotics have the potential to improve adherence and outcomes for...
Depot antipsychotic drugs, or long-acting injectable antipsychotics (LAIs), have been available sinc...
Background Long-acting injectable (LAI) antipsychotics have been shown to reduce risk of relapse in ...
INTRODUCTION: Long-acting injectable (LAI) antipsychotics are a useful but underutilized op...
Despite mixed results found in literature, long-acting injectable antipsychotics (LAIs) should offe...
Schizophrenia is a severe mental illness causing a high degree of disability. First-and second-gener...
AbstractObjectiveAs psychopathology and social functioning can worsen with repeated psychotic episod...
Background: Long acting injectable antipsychotics (LAI-APs) are considered a major advance in psychi...
International audienceBACKGROUND: Long-acting injectable (LAI) formulations are not widely used in r...
Purpose/Background Psychosis is a psychiatric disorder characterized by hallucinations and delusions...
Until relatively recently, long-acting injectable (LAI) formulations were only available for first-g...
Background: Long acting injectable (LAI) antipsychotics have been claimed to ensure treatment adhere...
Until relatively recently, long-acting injectable (LAI) formulations were only available for first-g...
Long-acting injectable (LAI) antipsychotics have the potential to improve adherence and outcomes for...
Depot antipsychotic drugs, or long-acting injectable antipsychotics (LAIs), have been available sinc...
Background Long-acting injectable (LAI) antipsychotics have been shown to reduce risk of relapse in ...
INTRODUCTION: Long-acting injectable (LAI) antipsychotics are a useful but underutilized op...
Despite mixed results found in literature, long-acting injectable antipsychotics (LAIs) should offe...
DOI
Add to ORKG